Skip to Main Content

INFORMATION FOR

Select Funding Opportunities

Click here to visit the NCI grant site.

Use your device's search function to find a specific disease or funding source.


Funding


Joint SPORE Developmental Research Program (DRP) Award – Cancer Disparities

The YCC Translational Research Office in collaboration with the Yale SPORE in Lung Cancer (YSILC) and the Yale Head and Neck SPORE (YHN-SPORE) have launched a new DRP award to provide support up to $50,000 for a translational pilot project focused on disparities-related cancer research in the field of Head and Neck and/or Lung cancer. Studies with a strong translational or clinical component that have the potential to evolve into, or be incorporated into, a full SPORE project and projects with multi-disciplinary collaborations and/or community-based participatory research studies are encouraged.

We encourage to submit your letter of intent (LOI) to anna.arnal@yale.edu

There is no deadline to apply, LOIs will we reviewed and eligible applicants will be invited to submit a full application online at: https://yale.infoready4.com/

The Blood and Marrow Transplant Clinical Trials Network - Core Clinical Centers (UG1 Clinical Trial Optional)

This NOFO invites applications to participate as Core Clinical Centers and Consortia in the BMT CTN. Core Clinical Centers and Consortia are expected to support and conduct multi-site trials to compare novel treatment approaches and management strategies for children and adults undergoing hematopoietic stem cell transplantation (HCT) for non-malignant and malignant blood diseases, either alone or in combination with novel adoptive cell-based therapies.

Application Deadline: October 2, 2023

Learn more about the BMT Core Clinical Centers>>

The Blood and Marrow Transplant Clinical Trials Network - Data Coordinating Center (U24)

This NOFO invites applications to participate as the Data Coordinating Center (DCC) for the BMT CTN. The overall goals are to identify and address gaps in HCT and adoptive cell therapy outcomes for blood diseases; rapidly disseminate study results to improve the scientific basis of the therapies being studied; provide a platform to train emerging clinical trial investigators; build a biorepository for future research that includes specimens linked to clinical data and outcomes from patients with non-malignant blood diseases who receive these therapies; and ultimately improve the life and quality of life for patients with blood diseases who receive HCT or adoptive cell therapies.

Application Deadline: October 2, 2023

Learn more about the BMT CTN>>

Charles H. Hood Foundation Child Health Research Awards Program

The intent of the Child Health Research Awards Program is to support newly independent faculty, provide the opportunity to demonstrate creativity, and assist in the transition to other sources of research funding.

Application Deadline: October 4, 2023

Learn more about the Charles H. Hood Award>>

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01)

This NOFO supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.

Application Deadline: October 13, 2023

Learn more about Global Health U01>>

Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01)

This NOFO supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the NOFO solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.

Application Deadline: October 13, 2023

Learn more about the U01 for Global Health>>

2024 Pershing Square Sohn Prize for Young Investigators in Cancer Research

The Pershing Square Sohn Prize for Young Investigators in Cancer Research provides greater New York City area-based early career scientists the freedom to take risks and pursue their boldest research at a stage when traditional funding is lacking. As of 2023, Prize winners each receive $250,000 a year for three years, totaling $750,000. At least six prizes are awarded annually.

Letter of Intent Due: October 30, 2023

Learn more about the Pershing YI Award>>

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R01)

The purpose of this NOFO is to invite basic observational or experimental behavioral and/or social science R01 applications that test how intrapersonal and interpersonal mechanisms of behavior change interact with, influence, or are influenced by characteristics of social networks, with implications for health. Research supported through this NOFO will examine at least two levels of analysis: interpersonal processes and social network characteristics.

Application Deadline: November 3, 2023

Learn more about the social networks R01>>

Leveraging Social Networks to Promote Widespread Individual Behavior Change (R34)

This NOFO invites R34 applications to support the planning activities necessary to develop social network interventions to promote health across the lifespan, especially in populations in which they are currently largely underdeveloped and untested (such as populations in mid- and late-life).

Application Deadline: November 3, 2023

Learn more about the social networks R32>>

Investigator-Initiated Research in Genomics and Health Equity (R01)

The purpose of this initiative is to support investigator-initiated research in genomics and health equity, with the ultimate goal of developing approaches, generating and disseminating data, and implementing metrics or interventions that will advance the equitable use of genomics to improve health in U.S. populations.

Application Deadline: November 8, 2023

Learn more about the Genomics and Health Equity RO1>>

Next Generation Chemistry Centers for Fusion Oncoproteins (UM1)

Through this NOFO, the NCI intends to create multidisciplinary research groups or partnerships for the discovery of pharmacological agents to treat fusion oncoprotein-driven childhood cancers.

Application Deadline: November 15, 2023

Learn more about the Next Generation UM1>>

Mechanisms of Fusion-Driven Oncogenesis in Childhood Cancers (U01)

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to solicit applications for basic research projects investigating the molecular mechanisms by which fusion oncoproteins drive pediatric cancers.

Application Deadline: November 15, 2023

Learn more about the NCI U01>>

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21)

The purpose of this FOA is to invite exploratory/developmental research grant applications (R21) for innovative informatics methods and algorithms to improve the acquisition, analysis, visualization, or interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

Application Deadline: November 17, 2023

Learn more about the R21 Informatics>>

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01)

The purpose of this FOA is to invite Cooperative Agreement (U01) applications for the development of enabling informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

Application Deadline: November 17, 2023

Learn more about the U01 for Cancer Research>>

Advanced Development of Informatics Technologies for Cancer Research and Management (U24)

The purpose of this FOA is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, analysis, visualization, and interpretation of data across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and cancer health disparities.

Application Deadline: November 17, 2023

Learn more about the U24 for Cancer Research>>

Sustained Support for Informatics Technologies for Cancer Research and Management (U24)

The purpose of this FOA is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high value informatics research resources to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum including cancer biology, cancer treatment and diagnosis, early cancer detection, risk assessment and prevention, cancer control and epidemiology, and/or cancer health disparities.

Application Deadline: November 17, 2023

Learn more about the U24 Informatics>>

Understanding and Mitigating Health Disparities experienced by People with Disabilities caused by Ableism (R01)

The goal of this NOFO is to encourage research to understand the impact of ableism on health outcomes. Research on the underlying mechanisms by which ableism adversely influences the health of persons with disabilities (PWD), as well as developing and/or testing interventions at a community or health systems level to mitigate adverse health effects of ableism are high priority.

Application Deadline: November 29, 2023

Learn more about the Health Disparities R01>>

Public Health Communication Messaging about the Continuum of Risk for Tobacco Products (U01)

The purpose of this NOFO is to invite applications for a Research Project (U01) that will utilize health communication research to better understand the impact that messaging about the continuum of risk for tobacco products may have on various segments of the population.

Application Deadline: December 6, 2023

Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01)

The purpose of this NOFO is to support Implementation Science for Cancer Control in People Living with HIV (PLWH) in Low- and Middle-Income Countries (LMICs) to accelerate the integration of evidence-based cancer control interventions for PLWH by leveraging existing HIV treatment and prevention infrastructure.

Application Deadline: December 15, 2023

Learn more about the PLWH LMIC award>>


Basic/Translational Research on Health Disparities in Underrepresented People Living with HIV (PLWH) and Cancer (R01/R21)
Through this FOA, the NCI intends to focus on the biological interactions of cancer health disparities in people living with HIV (PLWH) from underrepresented minority groups through basic mechanistic or translational studies to investigate how HIV interacts with health disparities to promote both non-AIDS and AIDS-defining cancer initiation, progression, and the resulting pathogenic disease sequelae.

Application Deadline: December 15, 2023


NCI Cancer Moonshot Scholars Diversity Program (CMSDP) (R01)

This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) and enhance the diversity of the cancer research workforce, while promoting scientific advancements in cancer. Investigators from diverse backgrounds, including those from underrepresented groups are encouraged to work with their institutions to apply.

Application Deadline: February 6, 2024


Understanding Expectancies in Cancer Symptom Management (R01)

This NOFO will solicit mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes.

Application Deadline: May 7, 2026

Learn more about the NOFO in Symptom Management>>